Study #2024-0112
A phase 1/2 study to evaluate the safety and efficacy of AZD0486 in adolescent and adult participants with relapsed or refractory B-Cell Acute Lymphoblastic Leukemia
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Gautam Borthakur
Department:
Leukemia
For general questions about clinical trials:
1-833-997-2081
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.